| Announce Date | 11/06/2025 |
| EPS Normalized Actual | $4.9 (Beat by $2.46) |
| EPS GAAP Actual | $4.9 (Beat by $2.46) |
| Revenue Actual | $0.216401B |
| Revenue Surprise | Beat by $216.401M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $3.19 |
| EPS GAAP Estimate | $3.19 |
| Revenue Estimate | $0.223412B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2027 | 15.0024 | 10.53 | 14.51776 | 15.7007 | 1 |
| Dec 2026 | 11.0016 | 14.36 | 10.30427 | 11.51422 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 5.05 | 1.82 | 0.216401B | 18.99% | 18.02M |
| FQ2 2025 (Jun 2025) | 5.57 | 2.5425 | 0.22192B | 7.06% | 22.71M |
| FQ1 2025 (Mar 2025) | 6.47 | 3.47 | 0.216433B | 4.54% | 29.48M |
| FQ4 2024 (Dec 2024) | 0 | -2.88 | 0.161442B | -0.76% | -21.34M |
| FQ3 2024 (Sep 2024) | 0.94 | 0.94 | 0.175317B | 24.91% | 175.32M |
| FQ2 2024 (Jun 2024) | 5.39 | 5.39 | 0.206245B | 38.26% | 206.25M |
| FQ1 2024 (Mar 2024) | 4.76 | 4.76 | 0.206614B | 37.55% | 206.61M |
| FQ4 2023 (Dec 2023) | 4.31 | 4.31 | 0.16267B | 24.87% | 162.67M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
3.19
Consensus Revenue Estimates
0.223412B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 4.21 | -- | 4.12671 | 4.31567 | 1 |
| FQ3 2027 (Sep 2027) | 2.16 | -- | 2.11727 | 2.21421 | 1 |
| FQ2 2027 (Jun 2027) | 4.32 | -- | 4.23454 | 4.42843 | 1 |
| FQ1 2027 (Mar 2027) | 4.85 | -- | 4.75405 | 4.97173 | 1 |
| FQ4 2026 (Dec 2026) | 3.52 | -- | 3.27179 | 4.13254 | 1 |
| FQ3 2026 (Sep 2026) | 1.48 | -241.22 | 1.37564 | 1.73755 | 1 |
| FQ2 2026 (Jun 2026) | 3.06 | -82.03 | 2.84423 | 3.5925 | 1 |
| FQ1 2026 (Mar 2026) | 3.19 | -102.82 | 2.96506 | 3.74512 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.16B | -- | 0.16B | 0.16B | 2 |
| FQ3 2027 (Sep 2027) | 0.18B | -- | 0.17B | 0.18B | 2 |
| FQ2 2027 (Jun 2027) | 0.23B | -- | 0.23B | 0.23B | 2 |
| FQ1 2027 (Mar 2027) | 0.21B | -- | 0.21B | 0.21B | 2 |
| FQ4 2026 (Dec 2026) | 0.22B | -- | 0.21B | 0.25B | 1 |
| FQ3 2026 (Sep 2026) | 0.22B | 2.92 | 0.21B | 0.25B | 1 |
| FQ2 2026 (Jun 2026) | 0.22B | 1.23 | 0.21B | 0.25B | 1 |
| FQ1 2026 (Mar 2026) | 0.22B | 3.12 | 0.21B | 0.25B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 3.23 | 5.05 | 1.82 | 36.04% |
| FQ2 2025 (Jun 2025) | 3.0275 | 5.57 | 2.5425 | 45.65% |
| FQ1 2025 (Mar 2025) | 3 | 6.47 | 3.47 | 53.63% |
| FQ4 2024 (Dec 2024) | 2.88 | 0 | -2.88 | -INF% |
| FQ3 2024 (Sep 2024) | 0.94 | 0.94 | 100% | |
| FQ2 2024 (Jun 2024) | 5.39 | 5.39 | 100% | |
| FQ1 2024 (Mar 2024) | 4.76 | 4.76 | 100% | |
| FQ4 2023 (Dec 2023) | 4.31 | 4.31 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.2B | $0.22B | $18.02M | 8.33% |
| FQ2 2025 (Jun 2025) | $0.2B | $0.22B | $22.71M | 10.24% |
| FQ1 2025 (Mar 2025) | $0.19B | $0.22B | $29.48M | 13.62% |
| FQ4 2024 (Dec 2024) | $0.18B | $0.16B | $-21.34M | -13.22% |
| FQ3 2024 (Sep 2024) | $0B | $0.18B | $175.32M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.21B | $206.25M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.21B | $206.61M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.16B | $162.67M | 100% |